Abstract
Study Design
Prospective consecutively enrolled cohort.
Objectives
To evaluate paraspinal muscle concentration of intravenously administered vancomycin, at predetermined time points, during posterior spinal fusion (PSF) with instrumentation in neuromuscular scoliosis (NMS).
Summary
Surgical site infection (SSI) after PSF for NMS can be a devastating complication, which may lead to prolonged antibiotic use, multiple additional surgical procedures, pseudarthroses, and sepsis. Because of significant morbidity of SSIs in NMS, the prophylactic use of vancomycin has been adopted at our institution as standard wound prophylaxis, despite any high-level evidence of its efficacy.
Methods
A prospective study of 20 patients who underwent definitive PSF for NMS and received vancomycin infusion preoperatively per institutional protocol. Serum levels were obtained immediately after infusion, at surgical incision, and then at 1, 2, and 4 hours post incision. Muscle tissue samples were simultaneously obtained at incision and at 1, 2, and 4 hours post incision. Samples were analyzed by a validated liquid chromatography–tandem mass spectrometry method.
Results
10 males and 10 females with a mean age of 14+11 years (9–20 years) received a mean infusion of 15.0 mg/kg vancomycin. Mean serum levels were 26.7 μg/mL after infusion, 18.1 at incision, 13.2 at 1 hour, 11.8 at 2 hours, and 7.6 at 4 hours post infusion. Mean muscle levels were 0.5 μg/mL at incision, 0.6 at 1 hour, 0.5 at 2 hours, and 0.7 at 4 hours post infusion. Mean serum levels reached minimum inhibitory concentration (MIC) for Staphylococcus aureus at incision and at all timepoints during surgery. Mean muscle vancomycin levels never reached MIC. No patients had any cardiac or kidney disease, and all patients had normal kidney function according to their preoperative laboratory values.
Conclusions
Using accepted guidelines for the administration of intravenous vancomycin preoperatively, serum levels reached MIC at incision and at all timepoints tested during PSF for neuromuscular scoliosis. At no timepoint tested did muscle levels reach MIC.
Level of Evidence
Level II.
Similar content being viewed by others
References
Banit DM, Iwinski Jr HJ, Talwalkar V, et al. Posterior spinal fusion in paralytic scoliosis and myelomeningocele. J Pediatr Orthop 2001;21:117–25.
Hatlen T, Song K, Shurtleff D, et al. Contributory factors to postoperative spinal fusion complications for children with myelomeningocele. Spine 2010;35:1294–9.
Mohamed Ali MH, Koutharawu DN, Miller F, et al. Operative and clinical markers of deep wound infection after spine fusion in children with cerebral palsy. J Pediatr Orthop 2010;30:851–7.
Borkhuu B, Borowski A, Shah SA, et al. Antibiotic-loaded allograft decreases the rate of acute deep wound infection after spinal fusion in cerebral palsy. Spine 2008;33:2300–4.
Harrod CC, Boykin RE, Hedequist DJ. Complications of infection in pediatric spine surgery. Pediatr Health 2009;3:579–92.
Hedequist D, Haugen A, Hresko T, et al. Failure of attempted implant retention in spinal deformity delayed surgical site infections. Spine 2009;34:60–4.
Linam WM, Margolis PA, Staat MA, et al. Risk factors associated with surgical site infection after pediatric posterior spinal fusion procedure. Infect Control Hosp Epidemiol 2009;30:109–16.
Milstone AM, Maragakis LL, Townsend T, et al. Timing of preoperative antibiotic prophylaxis: a modifiable risk factor for deep surgical site infections after pediatric spinal fusion. Pediatr Infect Dis J 2008;27:704–8.
Massie JB, Heller JG, Abitbol JJ, et al. Postoperative posterior spinal wound infections. Clin Orthop Relat Res 1992;284:99–108.
Olsen MA, Mayfield J, Lauryssen C, et al. Risk factors for surgical site infection in spinal surgery. J Neurosurg 2003;98(Suppl):149–55.
Ho C, Sucato DJ, Richards BS. Risk factors for the development of delayed infections following posterior spinal fusion and instrumentation in adolescent idiopathic scoliosis patients. Spine (Phila Pa 1976) 2007;32:2272–7.
Beiner JM, Grauer J, Kwon BK, et al. Postoperative wound infections of the spine. Neurosurg Focus 2003;15:E14.
Mackenzie WGS, Matsumoto H, Corona J, et al. Surgical site infection following spinal instrumentation for scoliosis: lessons learned from an analysis of 1352 procedures at three centers. J Child Orthop 2011;5:S29.
Murphy NA, Firth S, Jorgensen T, et al. Spinal surgery in children with idiopathic and neuromuscular scoliosis. What’s the difference? J Pediatr Orthop 2006;26:216–20.
Glotzbecker MP, Vitale MG, Shea KG, et al. Surgeon practices regarding infection prevention for pediatric spinal surgery. / Pediatr Orthop 2013;33:694–9.
Glotzbecker MP, Riedel MD, Vitale MG, et al. What’s the evidence? Systematic literature review of risk factors and preventive strategies for surgical site infections following pediatric spine surgery. J Pediatr Orthop 2013;33:694–9.
Vitale MG, Riedel MD, Glotzbecker MP, et al. Building consensus: development of a best practice guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery. J Pediatr Orthop 2013;33:471–8.
Javorska L, Krcmova LK, Solichova D, et al. Modern methods for vancomycin determination in biological fluids by methods based on high-performance liquid chromatography—a review. J Sep Sci 2016;39:6–20.
Payne CJ, Thomson AH, Stearns AT, et al. Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery. J Antimicrob Chemother 2011;66:2624–7.
Martin C, Alaya M, Mallet MN, et al. Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob Agents Chemother 1994;38:396–9.
Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706–15.
Devin CJ, Chotai S, McGirt MJ, et al. Intrawound vancomycin decreases the risk of surgical site infection after posterior spine surgery—a multicenter analysis. Spine (Phila Pa 1976) 2018;43:65–71.
Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002;19:285–90.
Author information
Authors and Affiliations
Corresponding author
Additional information
Author disclosures: JRG (none), JCS (none), SMBR (none), AME (none), SJL (none).
Washington University IRB approval was obtained.
Rights and permissions
About this article
Cite this article
Gregory, J.R., Smith, J.C., Brown-Riley, S.M. et al. Vancomycin Concentrations in Paraspinal Muscles During Posterior Spinal Fusions for Neuromuscular Scoliosis. Spine Deform 6, 736–740 (2018). https://doi.org/10.1016/j.jspd.2018.04.001
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jspd.2018.04.001